NASDAQ: STTK - Shattuck Labs, Inc.

Yield per half year: -41.25%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Shattuck Labs, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Shattuck Labs, Inc.

Shattuck Labs, Inc., биотехнологическая компания на клинической стадии, разрабатывает терапевтические средства для лечения рака и аутоиммунных заболеваний в Соединенных Штатах. Ведущим кандидатом на продукт компании является SL-172154, который находится в фазе 1 клинических испытаний для лечения рака яичников. Он также заключил соглашение о сотрудничестве с Takeda Pharmaceuticals для разработки SL-279252, который находится в стадии 1 клинических испытаний у пациентов с прогрессирующими солидными опухолями и лимфомой. Компания была основана в 2016 году со штаб-квартирой в Остине, штат Техас.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-10-09
ISIN US82024L1035
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.shattucklabs.com
Цена ао 1.19
Change price per day: -5.01% (0.838)
Change price per week: +2.98% (0.773)
Change price per month: -32.54% (1.18)
Change price per 3 month: -31.38% (1.16)
Change price per half year: -41.25% (1.355)
Change price per year: -92.48% (10.59)
Change price per 3 year: -76.73% (3.42)
Change price per year to date: -34.21% (1.21)
All parameters

Underestimation

Title Value Grade
P/S 169.81 1
P/BV 1.94 7
P/E 0 0
EV/EBITDA -1.82 0
Total: 3.63

Efficiency

Title Value Grade
ROA, % -54.71 0
ROE, % -60.33 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0478 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -83.26 0
Yield Ebitda, % 274.42 10
Yield EPS, % 70.77 8
Total: 7.6
More

Institutions Volume Share, %
FMR, LLC 7071174 14.89
Redmile Group, LLC 5619914 11.84
Prosight Management, LP 2782797 5.86
Adage Capital Partners GP L.L.C. 1752705 3.69
Franklin Resources, Inc. 1635821 3.45
Clark Estates Inc. (The) 1475648 3.11
Vanguard Group Inc 1317066 2.77
Point72 Asset Management, L.P. 670435 1.41
Laurion Capital Management, LP 661038 1.39
Maven Securities Limited 633876 1.34

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Morningstar Small-Cap Growth ETF 0.00651 596.94 0.72598
iShares Morningstar Small-Cap ETF 0.00302 391.25 1.60498
0.01494.11.17



Head Job title Payment Year of birth
Ms. Casi DeYoung Chief Business Officer 523.48k 1971 (54 years)
Mr. Andrew R. Neill M.B.A. Chief Financial Officer N/A 1986 (39 years)
Dr. Abhinav A. Shukla Ph.D. Chief Technical Officer 567.4k 1973 (52 years)
Dr. Thomas Lampkin Pharm.D. Senior Vice President of Regulatory Affairs N/A
Dr. Taylor H. Schreiber M.D., Ph.D. Co-Founder, CEO & Director 783.75k 1980 (45 years)
Mr. Conor Richardson CPA Vice President of Investor Relations N/A
Mr. George Fromm Ph.D. Chief Scientific Officer of ARC Platform N/A
Mr. Suresh de Silva Ph.D. Chief Scientific Officer of GADLEN Platform N/A
Dr. Stephen Stout J.D., Ph.D. General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer N/A 1975 (50 years)
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. Chief Medical Officer 1959 (66 years)

Address: United States, Austin, 1018 West 11th Street - open in Google maps, open in Yandex maps
Website: http://www.shattucklabs.com